切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2019, Vol. 15 ›› Issue (05) : 554 -559. doi: 10.3877/cma.j.issn.1673-5250.2019.05.012

所属专题: 文献

论著

妊娠期高血压患者血清微小RNA-210、-204-5p、-376c与其血液流变学指标的相关性及其诊断价值研究
刘杰1,(), 梁玉贞1   
  1. 1. 河北省黄骅市人民医院妇产二科 061100
  • 收稿日期:2019-06-03 修回日期:2019-09-12 出版日期:2019-10-01
  • 通信作者: 刘杰

Correlations between serum microRNA-210, -204-5p, -376c and hemorheology indexes in patients with pregnancy-induced hypertension and their diagnostic values

Jie Liu1,(), Yuzhen Liang1   

  1. 1. Department of Obstetrics and Gynecology, Huanghua Municipal People′s Hospital of Hebei Province, Huanghua 061100, Hebei Province, China
  • Received:2019-06-03 Revised:2019-09-12 Published:2019-10-01
  • Corresponding author: Jie Liu
  • About author:
    Corresponding author: Liu Jie, Email:
  • Supported by:
    Key Science and Technology Research Project of Health Commission of Hebei Province(20191175)
引用本文:

刘杰, 梁玉贞. 妊娠期高血压患者血清微小RNA-210、-204-5p、-376c与其血液流变学指标的相关性及其诊断价值研究[J]. 中华妇幼临床医学杂志(电子版), 2019, 15(05): 554-559.

Jie Liu, Yuzhen Liang. Correlations between serum microRNA-210, -204-5p, -376c and hemorheology indexes in patients with pregnancy-induced hypertension and their diagnostic values[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2019, 15(05): 554-559.

目的

探讨妊娠期高血压患者血清微小RNA(miRNA)-210、-204-5p、-376c与其血液流变学指标的相关性,以及其诊断价值。

方法

采用简单随机抽样方法,随机抽取2016年10月至2018年10月,于河北省黄骅市人民医院收治的妊娠期高血压患者80例为研究对象,并纳入研究组(n=80)。采用相同抽样方法,随机抽取同期于本院接受定期产前检查的80例中孕期正常妊娠妇女为对照,纳入对照组(n=80)。采用实时荧光定量PCR,检测2组受试者血清miRNA-210、-204-5p及-376c的相对表达量。采用全自动血细胞分析仪,检测2组受试者的血液流变学指标。2组受试者血清miRNA-210、-204-5p、-376c相对表达量及血液流变学指标比较,采用成组t检验。采用受试者工作曲线下面积(ROC-AUC),分析血清miRNA-210、-204-5p及-376c的相对表达量,对妊娠期高血压的诊断价值。采用Pearson相关系数分析妊娠期高血压患者血清miRNA-210、-204-5p及-376c的相对表达量与其血液流变学指标的相关性。本研究获得河北省黄骅市人民医院伦理委员会批准(批准文号:18101523),并且受试者均签署临床研究知情同意书。2组受试者的年龄、入组时孕龄、孕前人体质量指数、孕次、产次等一般临床资料分别比较,差异均无统计学意义(P>0.05)。

结果

①研究组患者血清miRNA-210、-204-5p的相对表达量分别为(1.56±0.35)与(1.78±0.40),均显著高于对照组的(0.59±0.11)与(0.72±0.15),研究组患者血清miRNA-376c的相对表达量为(0.33±0.09),却显著低于对照组的(1.24±0.32),2组上述指标分别比较,差异均有统计学意义(t=23.648、22.193、24.485,均为P<0.001)。②血清miRNA-210、-204-5p及-376c的相对表达量诊断妊娠期高血压的ROC-AUC分别为0.824(95%CI:0.738~0.902,P<0.001),0.871(95%CI:0.810~0.943,P<0.001),0.833(95%CI:0.746~0.908,P<0.001)。根据约登指数最大原则,血清miRNA-210、-204-5p及-376c的相对表达量,对于诊断妊娠期高血压的最佳临界值分别为0.696、1.512及0.712,此时其诊断妊娠期高血压的敏感度分别为83.3%、93.1%及85.0%,特异度分别为85.0%、75.0%及85.0%。③研究组患者的全血低切黏度(WRV)、低切还原黏度(LSRV)、血浆黏度(PV)分别为(7.9±1.5) mPa·s、(17.6±3.6) mPa·s、(1.6±0.3) mPa·s,分别显著高于对照组的(7.2±1.3) mPa·s、(15.6±3.4) mPa·s、(1.2±0.2) mPa·s,2组上述指标比较,差异均有统计学意义(t=3.154、P=0.002,t=3.613、P<0.001,t=9.923、P<0.001)。④妊娠期高血压患者血清miRNA-210相对表达量与其WRV、LSRV、PV,均呈正相关关系(r=0.343、P=0.002,r=0.415、P<0.001,r=0.287,P=0.001);血清miRNA-204-5p相对表达量与PV亦呈正相关关系(r=0.326、P=0.003);miRNA-376c相对表达量与WRV、LSRV,均呈正相关关系(r=0.317、P=0.004,r=0.351、P=0.001)。

结论

妊娠期高血压患者血清miRNA-210、-204-5p、-376c相对表达量与其血液流变学指标存在相关性,并且有望成为诊断妊娠期高血压的潜在生物标志物。

Objective

To investigate correlations between serum microRNA (miRNA)-210, -204-5p, -376c and hemorheology indexes in patients with pregnancy-induced hypertension and their diagnostic values.

Methods

Eighty patients with pregnancy-induced hypertension admitted in Huanghua Municipal People′s Hospital of Hebei Province from October 2016 to October 2018 were randomly selected as research subjects by simple random sampling method and enrolled into study group (n=80). And 80 normal pregnant women in the second trimester were randomly selected by the same method during the same period in the same hospital as control group (n=80). Real-time quantitative PCR was used to detect relative expression levels of serum miRNA-210, -204-5p, -376 of two groups. Hemorheology indexes were measured in two groups of subjects by automatic blood cell analyzer. Independent-samples t test was used to compare the relative expression levels of serum miRNA-210, -204-5p, -376 and hemorheology indexes between two groups. Area under receiver operating characteristic curve (ROC-AUC) was used to analyze the diagnostic values of relative expression levels of serum miRNA-210, -204-5p, -376 in diagnosis of pregnancy-induced hypertension. Pearson correlation coefficient was used to analyze the correlation between expression levels of serum miRNA-210, -204-5p and -376c and hemorheology indexes in patients with pregnancy-induced hypertension. This study was approved by the Ethics Committee of Huanghua Municipal People′s Hospital of Hebei Province (Approval No. 18101523). Clinical research informed consent was obtained from each participate. There were no statistical differences in the general clinical data such as age, gestational age at the time of enrollment, body mass index before pregnancy, gravidity, parity of patients, and so on (P>0.05).

Results

①The relative expression levels of serum miRNA-210 and miRNA-204-5p in study group were (1.56±0.35) and (1.78±0.40), respectively, which were higher than those (0.59±0.11), (0.72±0.15) in control group, respectively, and relative expression level of serum miRNA-376c in study group was (0.33±0.09), which was lower than that (1.24±0.32) in control group, and all the differences between two groups were statistically different (t=23.648, 22.193, 24.485; all P<0.001). ②The ROC-AUC of relative expression levels of serum miRNA-210, -204-5p, and -376c in diagnosis of pregnancy-induced hypertension were 0.824 (95%CI: 0.738-0.902, P<0.001), 0.871 (95%CI: 0.810-0.943, P<0.001), 0.833 (95%CI: 0.746-0.908, P<0.001), respectively. According to the maximum principle of Youden index, the optimal cut-off values of relative expression levels of serum miRNA-210, -204-5p, and -376c in diagnosis of pregnancy-induced hypertension were 0.696, 1.512, and 0.712, respectively. And the sensitivities for diagnosis of pregnancy-induced hypertension were 83.3%, 93.1% and 85.0%, respectively, and the specificities were 85.0%, 75.0% and 85.0%, respectively. ③The wholeblood reduced viscosity (WRV), low shear reduction viscosity (LSRV) and plasma viscosity (PV) of patients with pregnancy-induced hypertension in study group were (7.9±1.5) mPa·s, (17.6±3.6) mPa·s, (1.6±0.3) mPa·s, respectively, which were higher than those (7.2±1.3) mPa·s, (15.6±3.4) mPa·s, (1.2±0.2) mPa·s of healthy pregnant women in control group, respectively, and all the differences were statistically significant (t=3.154, P=0.002; t=3.613, P<0.001; t=9.923, P<0.001). ④There was a positive correlation between relative expression levels of serum miRNA-210 and WRV, LSRV and PV, respectively (r=0.343, P=0.002; r=0.415, P<0.001; r=0.287, P=0.001). There was a positive correlation between relative expression levels of serum miRNA-204-5p and PV (r=0.326, P=0.003). There was a positive correlation between relative expression levels of serum miRNA-376c and WRV, LSRV, respectively (r=0.317, P=0.004; r=0.351, P=0.001).

Conclusions

Relative expression levels of serum miRNA-210, miRNA-204-5p and miRNA-376c are associated with hemorheology indexes, and can be used as potential biomarkers for the diagnosis of pregnancy-induced hypertension, perhaps.

表1 2组受试者血清miRNA-210、-204-5p及-376c的相对表达量比较(±s)
表2 2组受试者血清miRNA-210、-204-5p及-376c的相对表达量诊断妊娠期高血压的ROC曲线分析结果
图1 2组受试者血清miRNA-210、-204-5p及-376c的相对表达量诊断妊娠期高血压的ROC曲线
表3 2组受试者血液流变学指标比较(±s)
[1]
高丽钦,陈惠娟,陈小琦,等. 血栓弹力图分析在妊娠高血压综合征中的应用价值[J]. 中华高血压杂志,2018, 26(12): 1177-1181.
[2]
张红,赵红美. 重度妊娠高血压综合征患者分娩时机及方式对母婴安全影响[J]. 社区医学杂志,2018, 16(14): 1163-1165.
[3]
Dragomir MP, Knutsen E, Calin GA. SnapShot: unconventional miRNA functions[J]. Cell, 2018, 174(4): 1038-1038.e1.
[4]
Fu G, Ye G, Nadeem L, et al. MicroRNA-376c impairs transforming growth factor-β and nodal signaling to promote trophoblast cell proliferation and invasion[J]. Hypertension, 2013, 61(4): 864-872.
[5]
Mei ZX, Huang BQ, Mo Y, et al. An exploratory study into the role of miR-204-5p in pregnancy-induced hypertension[J]. Exp Ther Med, 2017, 13(5): 1711-1718.
[6]
Biró O, Alasztics B, Molvarec A, et al. Various levels of circulating exosomal total-miRNA and miR-210 hypoxamiR in different forms of pregnancy hypertension[J]. Pregnancy Hypertens, 2017, 10(10): 207-212.
[7]
中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2015)[J]. 中华妇产科杂志,2015, 50(10): 721-728.
[8]
Ding C, He J, Liao W, et al. Regulation of WNT/β-catenin signaling by carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase (CAD) in colorectal cancer cell[J]. Int J Clin Exp Med, 2017, 10(12): 16243-16253.
[9]
Butalia S, Audibert F, Côté AM, et al. Hypertension Canada′s 2018 guidelines for the management of hypertension in pregnancy[J]. Can J Cardiol, 2018, 34(5): 526-531.
[10]
孙艳华. 妊娠高血压疾病患者血液流变学凝血和纤溶系统指标检测的临床意义[J]. 河北医学,2018, 24(9): 1557-1561.
[11]
李玉霞,柯鑫,纪泽虹. 早期护理干预对妊娠高血压轻度子痫前期患者血压与24 h尿蛋白的影响[J]. 护理实践与研究,2017, 14(9): 73-74.
[12]
Lu A, Disoma C, Zhou YZ, et al. Protein interactome of the deamidase phosphoribosylformylglycinamidine synthetase (PFAS) by LC-MS/MS[J]. Bioche Biophys Res Commun, 2019, 513(3): 746-752.
[13]
Liu Y, Wang F, Liu P, et al. MicroRNA-214-3p in the kidney contributes to the development of hypertension[J]. J Am Soc Nephrol, 2018, 29(10): 2518-2528.
[14]
Yang H, Zhang H, Meng F, et al. Differential expression of microRNA-411 and 376c is associated with hypertension in pregnancy[J]. Braz J Med Biol Res, 2019, 52(4): e7546.
[15]
曾军. MiR-204-5p/Six1反馈调控乳腺癌细胞表皮间质转化的机制研究[D]. 广州:南方医科大学,2016.
[16]
余梓浦. miR-204-5p抑制非小细胞肺癌生长的作用及分子机制研究[D]. 杭州:浙江大学,2016.
[17]
Késmárky G, Kenyeres P, Rábai M, et al. Plasma viscosity: a forgotten variable[J]. Clin Hemorheol Microcirc, 2008, 39(1-4): 243-246.
[18]
Cusumano P, Biscontin A, Sandrelli F, et al. Modulation of miR-210 alters phasing of circadian locomotor activity and impairs projections of PDF clock neurons in Drosophila melanogaster[J]. PLos Genet, 2018, 14(7): e1007500.
[19]
黎玉涵,孙小丽,罗喜平. 血清微小RNA在恶性肿瘤临床应用中的研究进展[J/CD]. 中华妇幼临床医学杂志(电子版), 2015, 11(1): 95-98.
[20]
何少仪,孙小丽,罗喜平. 血清microRNA在妇科恶性肿瘤临床诊断及其预后评价中的研究进展[J/CD]. 中华妇幼临床医学杂志(电子版), 2015, 11(6): 789-792.
[21]
Mazzone AL, Baker RA, McNicholas K, et al. Circulating and urinary miR-210 and miR-16 increase during cardiac surgery using cardiopulmonary bypass: a pilot study[J]. J Extra Corpor Technol, 2018, 50(1): 19-29.
[22]
Luo RC, Shao X, Xu P, et al. MicroRNA-210 contributes to preeclampsia by downregulating potassium channel modulatory factor 1[J]. Hypertension, 2014, 64(4): 839-845.
[1] 贺敬龙, 孙炜, 高明宏, 谢伟, 姜骆永, 何琦非, 岳家吉. 外泌体非编码RNA在骨关节炎发病机制中的研究进展[J]. 中华关节外科杂志(电子版), 2023, 17(04): 520-527.
[2] 陈甜甜, 王晓东, 余海燕. 双胎妊娠合并Gitelman综合征孕妇的妊娠结局及文献复习[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 559-568.
[3] 居晓庆, 金蕴洁, 王晓燕. 剖宫产术后瘢痕子宫患者再次妊娠阴道分娩发生子宫破裂的影响因素分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 575-581.
[4] 王蓓蓓, 董启秀, 郗红燕, 于庆云, 张丽君, 式光. 早孕期孕妇药物流产失败的影响因素分析与构建相关预测模型及其对药物流产成功的预测价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 588-594.
[5] 陈絮, 詹玉茹, 王纯华. 孕妇ABO血型联合甲状腺功能检测对预测妊娠期糖尿病的临床价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 604-610.
[6] 周梦玲, 薛志伟, 周淑. 妊娠合并子宫肌瘤的孕期变化及其与不良妊娠结局的关系[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 611-615.
[7] 周东杰, 蒋敏, 范海瑞, 高玲玲, 孔祥, 卢丹, 王丽萍. 非编码RNA在卵泡发育成熟中作用及其机制的研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 387-393.
[8] 冉晨曦, 沈如飞, 廖明钰, 廖倩, 周玲, 张玉玲, 隆敏. 垂体瘤孕妇的诊治与围分娩期管理[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 487-491.
[9] 陈樱, 陈艳莉. 高龄孕妇心率变异性原因及围产结局分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 295-301.
[10] 冯丹艳, 曹晓辉, 史玉霞. 血清脂联素与胎盘亮氨酸氨肽酶对妊娠期糖尿病患者妊娠结局的影响[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 302-308.
[11] 匡德凤, 李志国, 华绍芳, 薛凤霞. 高脂诱导孕鼠血清及胎盘组织脂肪酸结合蛋白-4及相关脂蛋白水平变化及其意义[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 338-344.
[12] 邬龙海, 黄淼, 龚云辉, 喻云倩. 血清趋化因子在妊娠期糖尿病孕妇中的临床价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 357-362.
[13] 王楚风, 蒋安. 原发性肝癌的分子诊断[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 499-503.
[14] 刘雪云, 范颖, 姚爱军, 张胜苗, 吕亚妮, 张冰清, 张晓宇, 刘恒. 基于微信小程序的个体化、全程护理干预对孕妇孕期体重及分娩结局的影响[J]. 中华临床医师杂志(电子版), 2023, 17(04): 455-460.
[15] 王晓怡, 洪凡, 陈晴晴, 孙雯. 新型冠状病毒感染疫情高发状态下封闭封控管理区孕产妇的管理方案研究[J]. 中华产科急救电子杂志, 2023, 12(02): 109-112.
阅读次数
全文


摘要